BHB
CELG

Bank Hapoalim BM’s Celgene Corp CELG Stock Holding History

Bank Hapoalim BM’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-7,653
Closed -$1.12M – 226
2017
Q3 		$1.12M Buy
7,653
+5,841
+322% +$796K 0.25% 75
2017
Q2 		$235K Buy
1,812
+85
+5% +$10.4K 0.06% 184
2017
Q1 		$215K Buy
+1,727
New +$207K 0.05% 184
2016
Q4 		– Sell
-1,410
Closed -$147K – 203
2016
Q3 		$147K Buy
+1,410
New +$153K 0.03% 188
2014
Q4 		– Sell
-3,460
Closed -$328K – 173
2014
Q3 		$328K Buy
+3,460
New +$312K 0.08% 131

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank Hapoalim BM's CELG Position: Q4 2017 in Review

Bank Hapoalim BM sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 7,653 shares — an estimated $1.12M sold.

Bank Hapoalim BM first reported a position in CELG in Q3 2014 and held it in 5 quarters. The position peaked at $1.12M in Q3 2017. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Bank Hapoalim BM reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Bank Hapoalim BM sold 7,653 Celgene Corp shares in Q4 2017, an estimated $1.12M.
  • Bank Hapoalim BM first reported a position in Celgene Corp in Q3 2014 and held it in 5 quarters.
  • Bank Hapoalim BM's Celgene Corp position peaked at $1.12M in Q3 2017.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Bank Hapoalim BM's 13F filing for Q4 2017, filed 5 Feb 2018.